Impact of the Implementation of Dance Therapy Workshops on the Quality of Life of Dependent Elderly People Institutionalized Within the Establishments of the Univi Group (Unidance)

Impact of the Implementation of Dance Therapy Workshops on the Quality of Life of Dependent Elderly People Institutionalized Within the Establishments of the Univi Group: Longitudinal Intervention Study

Dance is a multimodal activity involving motor, cognitive, sensory and sensory-motor skills as well as emotional and social skills. A growing body of research shows that the creative arts and physical exercise are able to alleviate disability, improve social interactions, and slow the progression of Alzheimer's disease and related disorders.

The Associative Group UNIVI wants to evaluate through this study the effects of the practice of dance on the quality of life of the people accommodated in its USLD and EHPAD

Study Overview

• Status: Not yet recruiting
• Conditions: Dance Therapy Workshop
• Intervention / Treatment: Other: Dance therapy

Detailed Description

This research is an interventional study involving the human person of category 2 involving only minimal risks and constraints, it is multicentric and longitudinal prospective. This is a before/after study to measure the effects of the implementation of a dance therapy activity on the quality of life of the elderly population housed in the 30 establishments of the univi group.

The dance therapy will be deployed in all the medico-social establishments participating in the study over a period of 12 weeks.

To do this, dance therapists will be recruited to provide these classes.

The dance-therapy will be carried out:

• in groups of 10 to 12 people who have given their informed consent,
• at least twice a week per group,

• over a period of 30 to 45 minutes maximum twice a week for 3 months. Several groups per establishment can be planned depending on the number of people who can and want to be included in the dance workshop.

  940 participant in the study will be inclued and followed at 1 month, 3 months and 6 months after the end of the dance therapy workshops.

• Study Type: Interventional
• Enrollment (Anticipated): 940
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 60 years to 110 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• People aged over 60
• Dependent elderly people residing in EHPAD or USLD including people under guardianship and curatorship
• People having signed an informated and weitten consent
• People with a minimum of language skills to understand instructions and simple questions

Exclusion Criteria:

• Participants in palliative care
• Contraindication to the practice of dance
• Severe cognitive and/or behavioral disorders that do not allow you to follow a dance workshop
• Permanent bed rest
• Non-affiliation to a social security scheme

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Before/after study; Before/after study to measure the effects of the implementation of a dance therapy activity on the quality of life of the elderly population	Other: Dance therapy; Before/after study to measure the effects of the dance therapy activity on the quality of life of the elderly population housed in the establishments of UNIVI group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
QOL-AD NH scale	The QOL-AD is a brief 13-item measure designed specifically to obtain an assessment of the patient's quality of life from both the patient and the caregiver. It was developed for people with dementia, based on feedback from patients, caregivers and experts, to maximize construct validity and ensure measurement focuses on areas of quality of considered important in older adults with cognitive impairment The measurement of 13 items, rated on a four-point scale, of which 1 is poor and 4 excellent. Total partitions range from 13 to 52.	Eight months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Tinetti test: assessement of walking and balance	The Tinetti test is an effective and reproductible tool for the assessement of the risk of falling, its administration time is approximately 5 to 10 minutes and evaluates static and dynamic balance	Eight months
Get up and Go test	This test evaluates the transfers sitting, standing, walking and changes of direction of the person. . Interpretation: risk of falling if score greater than or equal to 9	Eight months
Time up and Go test	The time up and go test is the timed version of the get up and go test. The subject seated on a chair must get up, walk 3 meters in front of him, return to his chair and sit down. The score is given by the time in seconds. Interpretation: risk of falling if the score is greater than or equal to 21 seconds.	Eignt months
NPI-ES: NEUROPSYCHIATRIC INVENTORY	assesses the presence of behavioral problems in people with dementia. . a score of Ten behavioral domains and 2 neurovegetative variables are taken into account.	Eight months
The mini GDS	The mini GDS (Geriatric Depression Scale) aims to identify the person's risk of depression. It consists of 4 simple questions that must be answered with "yes" or "no".	Eight months

Collaborators and Investigators

• Sponsor: Centre Médical Porte Verte

Study record dates

Study Major Dates

• Study Start (Anticipated): September 1, 2022
• Primary Completion (Anticipated): July 31, 2023
• Study Completion (Anticipated): March 31, 2024

Study Registration Dates

• First Submitted: June 17, 2022
• First Submitted That Met QC Criteria: June 23, 2022
• First Posted (Actual): June 29, 2022

Study Record Updates

• Last Update Posted (Actual): June 29, 2022
• Last Update Submitted That Met QC Criteria: June 23, 2022
• Last Verified: June 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: 2022-A01255-38

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No